Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jing Xu, Zhuanghui Hao, Xian Chen, Minglin Hong, Daniel muteb Muyey, Xiuhua Chen & Hongwei Wang. (2022) The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing. Leukemia & Lymphoma 63:10, pages 2321-2329.
Read now
Read now
Yun Lin, Yaping Wang, Yi Zheng, Zechuan Wang, Yanni Wang & Shaoyuan Wang. (2020) Clinical characteristics and prognostic study of adult acute myeloid leukemia patients with ASXL1 mutations. Hematology 25:1, pages 446-456.
Read now
Read now
Katerina Kakosaiou, Fotios Panitsas, Aggeliki Daraki, Maria Pagoni, Paraskevi Apostolou, Agapi Ioannidou, Ioanna Vlachadami, Theodoros Marinakis, Chara Giatra, Diamantina Vasilatou, Constantina Sambani, Vassiliki Pappa & Kalliopi N. Manola. (2018) ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics. Leukemia & Lymphoma 59:10, pages 2439-2446.
Read now
Read now
Yun Lin, Yi Zheng, Ze-Chuan Wang & Shao-Yuan Wang. (2016) Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis. Hematology 21:8, pages 454-461.
Read now
Read now
Hsin-An Hou & Hwei-Fang Tien. (2016) Mutations in epigenetic modifiers in acute myeloid leukemia and their clinical utility. Expert Review of Hematology 9:5, pages 447-469.
Read now
Read now
Velizar Shivarov, Ralitza Gueorguieva, Milena Ivanova & Ramon V. Tiu. (2015) ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia. Leukemia & Lymphoma 56:6, pages 1881-1883.
Read now
Read now
Lisa Pleyer & Richard Greil. (2015) Digging deep into “dirty” drugs – modulation of the methylation machinery. Drug Metabolism Reviews 47:2, pages 252-279.
Read now
Read now
Articles from other publishers (5)
Fatma Al-Bulushi, Rahma Al-Riyami, Zainab Al-Housni, Bushra Al-Abri & Murtadha Al-Khabori. (2022) Impact of mutations in epigenetic modifiers in acute myeloid leukemia: A systematic review and meta-analysis. Frontiers in Oncology 12.
Crossref
Crossref
Ibolya Czegle, Austin L. Gray, Minjing Wang, Yan Liu, Jun Wang & Edina A. Wappler-Guzzetta. (2021) Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies. Life 11:12, pages 1351.
Crossref
Crossref
Bas J. Wouters & Ruud Delwel. (2016) Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia. Blood 127:1, pages 42-52.
Crossref
Crossref
Kareem Jamani & Carolyn Owen. (2015) Update on recurrent genetic aberrations in acute myeloid leukemia. International Journal of Hematologic Oncology 4:5, pages 179-190.
Crossref
Crossref
Sophia Yohe. (2015) Molecular Genetic Markers in Acute Myeloid Leukemia. Journal of Clinical Medicine 4:3, pages 460-478.
Crossref
Crossref